[Federal Register Volume 83, Number 239 (Thursday, December 13, 2018)]
[Notices]
[Page 64159]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-27029]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-392]
Bulk Manufacturer of Controlled Substances Application: Eli-
Elsohly Laboratories
ACTION: Notice of application.
-----------------------------------------------------------------------
DATES: Registered bulk manufacturers of the affected basic classes, and
applicants therefore, may file written comments on or objections to the
issuance of the proposed registration on or before February 11, 2019.
ADDRESSES: Written comments should be sent to: Drug Enforcement
Administration, Attention: DEA Federal Register Representative/DPW,
8701 Morrissette Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: The Attorney General has delegated his
authority under the Controlled Substances Act to the Administrator of
the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority
to exercise all necessary functions with respect to the promulgation
and implementation of 21 CFR part 1301, incident to the registration of
manufacturers, distributors, dispensers, importers, and exporters of
controlled substances (other than final orders in connection with
suspension, denial, or revocation of registration) has been redelegated
to the Assistant Administrator of the DEA Diversion Control Division
(``Assistant Administrator'') pursuant to section 7 of 28 CFR part 0,
appendix to subpart R.
In accordance with 21 CFR 1301.33(a), this is notice that on
November 22, 2017, Eli-Elsohly Laboratories, Mahmoud A. Elsohly Ph.D.,
5 Industrial Park Drive, Oxford, Mississippi 38655 applied to be
registered as a bulk manufacturer of the following basic classes of
controlled substances:
------------------------------------------------------------------------
Drug
Controlled substance code Schedule
------------------------------------------------------------------------
Marihuana Extract...................... 7350 I
Marihuana.............................. 7360 I
Tetrahydrocannabinols.................. 7370 I
Dihydromorphine........................ 9145 I
Amphetamine............................ 1100 II
Methamphetamine........................ 1105 II
Cocaine................................ 9041 II
Codeine................................ 9050 II
Dihydrocodeine......................... 9120 II
Oxycodone.............................. 9143 II
Hydromorphone.......................... 9150 II
Ecgonine............................... 9180 II
Hydrocodone............................ 9193 II
Morphine............................... 9300 II
Thebaine............................... 9333 II
------------------------------------------------------------------------
The company plans to manufacture the listed controlled substances
for product development and reference standards. In reference to drug
codes 7360 (marihuana) and 7370 (THC), the company plans to isolate
these controlled substances from procured 7350 (marihuana extract). In
reference to drug code 7360 (marihuana), no cultivation activities are
authorized for this registration. No other activities for these drug
codes are authorized for this registration.
Dated: December 3, 2018.
John J. Martin,
Assistant Administrator.
[FR Doc. 2018-27029 Filed 12-12-18; 8:45 am]
BILLING CODE 4410-09-P